Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Multifocal tDCS-EEG Protocol for Improving Symptoms of Mild Cognitive Impairment and Early Dementia [NA]
A protocol study evaluating multifocal transcranial direct current stimulation (tDCS) with EEG monitoring to improve symptoms in mild cognit…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Randomized Controlld Trial of Dementia Education Resources for Action [NA]
A randomized controlled trial evaluating dementia education resources for action is registered; recruitment has not yet begun.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Amyloid Monoclonal Antibody Treatment in PD Patients With Coexistent AD Pathology [NA]
This is a clinical trial status update for an amyloid monoclonal antibody treatment in Parkinson disease patients with coexistent Alzheimer'…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Alzheimer's Disease and Faecal Microbiota Transplantation -a Pilot Study [Phase 1]
Phase 1 pilot clinical trial evaluating faecal microbiota transplantation for Alzheimer’s disease is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5) [Phase 3]
Phase 3 ADEPT-5 is evaluating the safety and efficacy of KarXT plus KarX-EC for psychosis associated with Alzheimer's disease; the trial is …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Postmarketing Study of LEQEMBI in South Korean Participants With Alzheimer's Disease
Postmarketing study of LEQEMBI (lecanemab) in South Korean participants with Alzheimer's disease. Recruitment is ongoing.
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2) [Phase 3]
Phase 3 ADEPT-2 trial evaluating KarXT for psychosis in Alzheimer's disease; current status is active but not recruiting.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: The Nightlight Falls Prevention Study [NA]
The Nightlight Falls Prevention Study is currently enrolling by invitation, led by the University of North Carolina, Chapel Hill, investigat…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3) [Phase 3]
This ClinicalTrials.gov entry describes a Phase 3 study evaluating the long-term efficacy and safety of KarXT plus KarX-EC for agitation in …
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) Diet in Stroke Patients Patients [NA]
Update on the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet trial in stroke patients. The study is currently activ…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Stem Cell Therapy for Early Alzheimer's Disease [Phase 1, Phase 2]
A Phase 1/2 clinical trial is recruiting to evaluate a stem cell therapy for early Alzheimer's disease.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease [Phase 1]
This is a first-in-human Phase 1 study of LY3954068 in adults with early symptomatic Alzheimer's disease, and it is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Sleep Disturbance and Emotion Regulation Brain Dysfunction as Mechanisms of Neuropsychiatric Symptoms in Alzheimer's Dementia [NA]
Stanford University is conducting a study examining sleep disturbance and emotion regulation brain dysfunction as potential mechanisms for n…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Combating Alzheimer's Through Sleep and Exercise [NA]
This University of Miami trial is examining whether sleep and exercise can impact Alzheimer’s disease and dementia and is currently recruiti…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Effect of CAFfeine on Cognition in Alzheimer's Disease [Phase 3]
A Phase 3 clinical trial investigating CAFfeine for cognitive outcomes in Alzheimer's disease is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Primary Care-Based Psychosocial Intervention To Improve Cognitive & Depression Outcomes in Older Adults With MCI & Early Stage AD [NA]
This clinical trial, sponsored by Weill Medical College of Cornell University, is recruiting to test a primary care-based psychosocial inter…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004) [Phase 2]
This clinical trial update reports that MK-2214-004, a Phase 2 study of MK-2214 in people with early Alzheimer's disease, is currently recru…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Genetics of Mendelian Forms of Young Onset Alzheimer Disease [NA]
A completed clinical trial investigating the genetics of Mendelian (autosomal dominant) forms of young-onset Alzheimer's disease. The study …
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study to Assess Safety and Tolerability and to Explore Efficacy of NSC001 in Mild to Moderate Alzheimer's Disease [Phase 1, Phase 2]
Clinical trial update for NSC001 assessing safety, tolerability, and exploratory efficacy in mild-to-moderate Alzheimer's disease; the study…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Improving Dementia Care in Primary Practice [NA]
This clinical trial aims to improve dementia care in primary practice and involves participants with Alzheimer’s disease and mild cognitive …
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Biomarker-based Trial of NPC-1 for Alzheimer's Pathology [Phase 1, Phase 2]
Massachusetts General Hospital is conducting a Phase 1/2 biomarker-based trial of NPC-1 for Alzheimer's pathology, currently recruiting in A…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Study to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD) [Phase 2]
This Phase 2 trial is evaluating the safety and efficacy of PRI-002 in patients with mild cognitive impairment due to Alzheimer's disease an…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia [Phase 2, Phase 3]
A clinical-trial update indicates ongoing phase 2 and phase 3 studies to assess safety and efficacy of EXV-802 and EXV-801 for agitation in …
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Study to Evaluate the Effect of HT-4253 for the Prevention of Alzheimer's Disease in APOE4 Carriers [Phase 2]
A Phase 2 study to evaluate HT-4253 for preventing Alzheimer's disease in APOE4 carriers, currently not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Feasibility of Improving Glycemia With Heat Therapy to Prevent AD [NA]
This clinical trial update notes a feasibility study sponsored by the University of Kansas Medical Center investigating whether heat therapy…